Status:
COMPLETED
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
Lead Sponsor:
Emory University
Collaborating Sponsors:
Atlanta Clinical and Translational Science Institute
Conditions:
Phenylketonuria
Eligibility:
FEMALE
12-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if taking supplemental DHA improves measures of processing speed and executive function in teen and adult women with PKU.
Eligibility Criteria
Inclusion
- Females
- Phenylketonuria
- Ages 12 years and older
- Able to complete neuropsychological testing
Exclusion
- Pregnancy
- Currently taking DHA supplement
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00892554
Start Date
June 1 2007
End Date
January 1 2010
Last Update
December 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322